The special litigation committee is a powerful tool, and corporations should not be allowed to resort to it prematurely: an analysis from Joseph Pull and Scott Benson, published in the most recent volume of the University of St. Thomas Law Journal.Read More
In 2016, the pharmaceutical company Merck won a $200 million jury verdict against its competitor Gilead, based on Merck’s claim that Gilead infringed Merck’s drug patents. But three months later the judge completely barred Merck from enforcing its patents against Gilead, after concluding that Merck had “unclean hands” as a result of a “pervasive pattern...Read More
You can now make a federal case out of a lost trade secret. The Defend Trade Secrets Act of 2016, which became law on May 11, 2016, allows businesses and individuals to bring civil lawsuits in federal court for misappropriation of their trade secrets. Previously, an action based on trade secrets had to be based...Read More